Study on connective tissue growth factor expressed in patients with ST-segment elevation myocardial infarction

Connective Tissue Growth Factor was significantly expressed in ST-segment elevation Myocardial Infarction patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN20467848

Enrollment

194

Registered

2015-08-31

Start date

2013-07-03

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. ST-segment elevation myocardial infarction 2. Angina Circulatory System 1. ST-segment elevation myocardial infarction 2. Angina

Interventions

All the patients received conventional intensive medical treatment and elective PCI after hospitalization. The door-to-balloon time was (278.3±43.2)hours for these 94 patients from chest pain to infar

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Suffering from one of the following: 1. Acute ST elevation myocardial infarction without direct PCI 2. Thrombolytic indications 3. Unstable angina

Exclusion criteria

Exclusion criteria: 1. Previous severe valvular disease 2. Cardiomyopathy 3. Severe chronic heart failure 4. Persistent atrial fibrillation.

Design outcomes

Primary

Measure	Time frame
The serum level of connective tissue growth factor (CTGF) and Creatine kinase-MB (CKMB) maximal value.	—

Secondary

Measure	Time frame
1. Ventricular ejection fraction. 2. Mortality Rate.	—

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026